Myriad Genetics (MYGN) Asset Utilization Ratio (2011 - 2026)

Myriad Genetics (MYGN) has 16 years of Asset Utilization Ratio data on file, last reported at 1.2 in Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 1.2, up 46.93% year-over-year; the trailing twelve-month figure through Mar 2026 was 1.2 (up 46.93% YoY), and the FY2025 annual result was 0.95, up 23.41% from the prior year.
• Asset Utilization Ratio rose to 1.2 in Q1 2026 per MYGN's latest filing, from 1.15 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 1.2 in Q1 2026 and troughed at 0.53 in Q1 2022.
• A 5-year average of 0.76 and a median of 0.69 in 2024 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2022 and 2025: Asset Utilization Ratio decreased 11.26% in 2022, then soared 54.47% in 2025.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.56 in 2022, then advanced by 16.59% to 0.66 in 2023, then rose by 21.05% to 0.79 in 2024, then soared by 44.69% to 1.15 in 2025, then gained by 4.51% to 1.2 in 2026.
• Business Quant data shows MYGN's Asset Utilization Ratio at 1.2 in Q1 2026, 1.15 in Q4 2025, and 1.17 in Q3 2025.